Tri Locum Partners L.P. 13F annual report

Tri Locum Partners L.P. is an investment fund managing more than $204 billion ran by Christabel Syham. There are currently 23 companies in Syham’s portfolio. The largest investments include Abbvie Inc and Teva Pharmaceutical Inds Ltd, together worth $44.7 billion.

$204 billion Assets Under Management (AUM)

As of 7th February 2024, Tri Locum Partners L.P.’s top holding is 167,807 shares of Abbvie Inc currently worth over $26 billion and making up 12.8% of the portfolio value.Relative to the number of outstanding shares of Abbvie Inc, Tri Locum Partners L.P. owns more than approximately 0.1% of the company.In addition, the fund holds 1,794,335 shares of Teva Pharmaceutical Inds Ltd worth $18.7 billion. The third-largest holding is Regeneron Pharmaceuticals worth $14.1 billion and the next is Ge Healthcare Technologies I worth $13.3 billion, with 171,676 shares owned.

Currently, Tri Locum Partners L.P.'s portfolio is worth at least $204 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Tri Locum Partners L.P.

The Tri Locum Partners L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Christabel Syham serves as the Chief Compliance Officer at Tri Locum Partners L.P..